MtoZ Biolabs Announces Advanced C-Terminal Sequencing Service for Biochemical Research

MtoZ Biolabs provides advanced C-terminal sequencing with LC-MS/MS, offering high sensitivity, specificity, and compliance with ICH Q6B. Services include comprehensive analysis, detailed reports, and regulatory-compliant results to support biopharmaceutical research and development.

Boston, Massachusetts, United States – September 18, 2024 /MarketersMEDIA/ —

MtoZ Biolabs offers state-of-the-art C-terminal sequencing service utilizing LC-MS/MS technology, ensuring high sensitivity and specificity while maintaining compliance with ICH Q6B regulatory guidelines. Our one-stop service provides customized experimental protocols, detailed data reports and accurate C-terminal amino acid sequence information to support the research and development of various biological products.

Service Advantages

1.Comprehensive C-Terminal Analysis
Detailed examination of the protein’s C-terminal end, including identification of post-translational modifications (PTMs).

2.Advanced LC-MS/MS Technology
Utilizes cutting-edge LC-MS/MS for accurate C-terminal sequencing across various biological samples, including proteins, antibodies, peptides, vaccines, and recombinant collagen, ect.

3.Regulatory Compliance
Conforms to ICH Q6B guidelines, ensuring reliable and reproducible results.

Deliverables

1.Experimental Procedures
2.Parameters of Liquid Chromatography and Mass Spectrometry
3.MS Raw Data Files
4.N/C-Terminal Amino Acid Sequences

About the company: MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The name of MtoZ represents “mass to charge ratio” in mass spectrometry analysis, as most of our services are provided based on our well-established mass spectrometry platforms. Our services allow for the rapid and efficient development of research projects, including protein analysis, proteomics, and metabolomics programs.

MtoZ Biolabs is specialized in quantitative multiplexed proteomics and metabolomics applications through the establishment of state-of-the-art mass spectrometry platforms, coupled with high-performance liquid chromatography technology. We are committed to developing efficient, and effective tools for addressing core bioinformatics problems. With a continuing focus on quality, MtoZ Biolabs is well equipped to help you with your needs in proteomics, metabolomics, bioinformatics, and biopharmaceutical research. Our ultimate aim is to provide more rapid, high-throughput, and cost-effective analysis, with exceptional data quality and minimal sample consumption.

Contact Info:
Name: MtoZ Biolabs
Email: Send Email
Organization: MtoZ Biolabs
Address: 155 Federal Street, Suite 700, Boston, MA 02110, USA
Phone: +1-857-362-9535
Website: https://www.mtoz-biolabs.com/

Release ID: 89141181

In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.